Consensus bioMérieux

Equities

BIM

FR0013280286

Market Closed - Euronext Paris 11:35:04 2024-04-26 am EDT After market 01:54:58 pm
101.5 EUR +2.01% Intraday chart for bioMérieux 101.7 +0.20%

Evolution of the average Target Price on bioMérieux

Price target over the last 5 years

History of analyst recommendation changes

d202fd55b22f1c81e23d8.1OARPSK3_4nDP4TGSC2skOjVxRegXF2mpKoQRMRo5e4.ratCYhPoz9qhDbyTBFrdwd_njE7DLROQ4M5HCa9QgNelv3BUU-ao6rJM0Q~d194e1e4fbac0f20846d6ab3267d8d64
BioMérieux: share price rises, analyst remains Buy CF
BIOMÉRIEUX : Berenberg raises its target CF
Deutsche Bank Initiates BioMérieux Coverage at Purchase MT
BIOMÉRIEUX : Deutsche Bank initiates buy coverage CF
Stifel Reaffirms bioMérieux at Buy, Lifts PT MT
BIOMÉRIEUX : Stifel raises target price CF
Invest Securities Lifts BioMérieux PT, Maintains at Buy MT
Oddo BHF Raises bioMérieux PT, Affirms Neutral Recommendation MT
BIOMÉRIEUX : Oddo BHF raises its target price CF
BIOMÉRIEUX : Invest Securities raises its target CF
BIOMERIEUX : A strong start to 2024 Alphavalue
Berenberg Upgrades BioMérieux to Buy from Hold, Lifts PT MT
BIOMÉRIEUX : Berenberg upgrades its recommendation to 'buy CF
BioMérieux: Invest Securities reiterates its opinion CF
Invest Securities Keeps BioMérieux at Buy, Reduces PT MT
BIOMÉRIEUX : Invest Securities remains positive, reduces its target CF
BIOMERIEUX : Good end to 2023; routine testing dynamics remain intact Alphavalue
Invest Securities Lowers BioMérieux's PT, Keeps Buy Rating MT
BIOMERIEUX : Healthy performances across the non-COVID-19 offerings; guidance maintained Alphavalue
BIOMÉRIEUX : Invest Securities remains Buy after sales figures CF
Chinese headwinds could be more severe than expected Alphavalue
Stifel Lifts bioMérieux PT, Maintains Buy Rating MT
BIOMÉRIEUX : Stifel raises its target price CF
Invest Securities Maintains BioMérieux at Buy, Trims PT MT
BioMérieux: buoyed by brokers' comments CF
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
99.5 EUR
Average target price
112.2 EUR
Spread / Average Target
+12.77%
High Price Target
128 EUR
Spread / Highest target
+28.64%
Low Price Target
90 EUR
Spread / Lowest Target
-9.55%

Consensus detail

Consensus revision (last 18 months)

Analysts covering bioMérieux

Deutsche Bank Securities
Stifel Nicolaus
ODDO BHF
Invest Securities
alphavalue Anas Patel
Berenberg Bank
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
  1. Stock Market
  2. Equities
  3. BIM Stock
  4. Consensus bioMérieux